Contract HHSO100201200005C

Velico Medical, Inc. · Department Of Health And Human Services · September 28, 2012

Cost Plus Fixed FeeFull & Open CompetitionNAICS 541711

Velico Medical, Inc. was awarded a federal contract by Department Of Health And Human Services (Office Of Assistant Secretary For Preparedness And Response) on September 28, 2012 for $41.51 million of work in research and development in biotechnology. It was awarded under full and open competition. The contract has been modified 22 times since the base award It uses cost-plus contract pricing. The most recent modification was on January 31, 2022. If all options are exercised, the contract could reach $90.01 million.

Obligated to date
$41.51M
$41,507,906
Potential value
$90.01M
if all options exercised
Modifications
22
Latest January 31, 2022

Contract details

PIID
HHSO100201200005C
Award type
Pricing
Cost Plus Fixed Fee
Set-aside
No Set Aside Used.
Competition
Full And Open Competition
NAICS
541711 · Research And Development In Biotechnology
Product / service
Health R&D Services; Health Care Services; Experimental Development
First action
September 28, 2012
Latest action
January 31, 2022

Description

PROVIDE ADDITIONAL FUNDING TO OPTION 3/CLIN0004 AND EXTEND POP THROUGH 6/3/2022

Modification timeline

  • January 31, 2022
    Mod P00022
    $453.7K
  • December 17, 2021
    Mod P00021
    PROVIDE A NO-COST EXTENSION THROUGH JANUARY 31, 2022 AS REQUESTED BY THE CONTRACTOR.
    $0
  • November 30, 2021
    Mod P00020
    INCORPORATE BY EXECUTIVE ORDER 14042 - FAR DEVIATION CLAUSE 52.223-99
    $0
  • September 30, 2021
    Mod P00019
    DE-OBLIGATE REMAINING FY2016 EXPIRING FUNDS FROM CLIN0002
    $-1.8K
  • September 22, 2021
    Mod P00018
    PROVIDE ADDITIONAL FUNDING TO OPTION 3/CLIN0004 AND EXTEND POP THROUGH 12/17/2021
    $154.4K
  • July 13, 2021
    Mod P00017
    PROVIDE ADDITIONAL FUNDING TO OPTION 3/CLIN0004 AND EXTEND POP THROUGH 9/30/2021
    $988.6K
  • May 4, 2021
    Mod P00016
    CHANGE COR FROM ASHLEY CECERE TO RICHARD ANDREW MORENO
    $0
  • April 13, 2021
    Mod P00015
    PROVIDE A NO-COST EXTENSION THROUGH JULY 31, 2021 AS REQUESTED BY THE CONTRACTOR.
    $0
  • February 24, 2021
    Mod P00014
    CONTRACT IS FOR THE DEVELOPMENT OF A SYSTEM TO SPRAY DRY PLASMA.
    $642.2K
  • June 26, 2020
    Mod P00013
    CONTRACT IS FOR THE DEVELOPMENT OF A SYSTEM TO SPRAY DRY PLASMA.
    $2.31M

Similar contracts

RecipientAgencyDateObligated
University Of IllinoisDepartment Of Health And Human ServicesMarch 26, 2026$2.27M
Battelle Memorial InstituteDepartment Of Health And Human ServicesMarch 25, 2026$9.65M
University Of Texas Medical Branch At GalvestonDepartment Of Health And Human ServicesMarch 23, 2026$1.61M
Regeneron Pharmaceuticals IncDepartment Of Health And Human ServicesMarch 19, 2026$8.60M
Battelle Memorial InstituteDepartment Of Health And Human ServicesMarch 17, 2026$2.23M
Battelle Memorial InstituteDepartment Of Health And Human ServicesMarch 17, 2026$2.22M

Top contractors in NAICS 541711

Lifetime obligated dollars across all federal contracts in this NAICS code.

Track this on BesaGov

Get a free weekly email when this changes — new awards, new sub-awards, new opportunities. No login required.

✓ You’re on the list. We’ll never spam you.

Helpful guides

Continue learning

See all guides →
More on BesaGov

Keep researching

Track this contract, set alerts on similar opportunities, and build proposal pipelines on BesaGov.
Sign up free

Frequently asked questions

What is contract HHSO100201200005C?

Contract HHSO100201200005C is a federal contract awarded to Velico Medical, Inc. by Department Of Health And Human Services on September 28, 2012 for $41.51 million of work classified under RESEARCH AND DEVELOPMENT IN BIOTECHNOLOGY. It has been modified 22 times since the base award.

Who won contract HHSO100201200005C?

Velico Medical, Inc. won contract HHSO100201200005C from Department Of Health And Human Services.

How much is contract HHSO100201200005C worth?

Contract HHSO100201200005C has obligated $41.51 million to date, with a total potential value of $90.01 million if all options are exercised.